- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT01683903
Comparison of Cardiac Rehabilitation Benefits Between Coronary and Non-coronary Patients Through a 24 Months Follow-up After Myocardial Infarction: the "INCARD" Study (INCARD)
Comparison of Cardiac Rehabilitation Benefits Between Coronary and Non-coronary Patients Through a 24 Months Follow-up : the "INCARD" Study
Studienübersicht
Status
Bedingungen
Detaillierte Beschreibung
We will undertake a prospective follow-up study of 150 rehabilitated patients with heart failure (75 C; 75 NC). The main objective will be to compare the benefits of rehabilitation between coronary and non-coronary patients based on functional improvement i.e. improvements of VO2max, LVEF (ultrasound method and/or isotopic), 6-min walk test, Minnesota index of quality of life. In addition, clinical outcomes (HR, SBP, DBP, BMI) and paraclinical data (creatinine clearance) will be measured as patients' standard clinical follow-up .
Clinical data of the patients admitted to the cardiac rehabilitation, including heart failure patients (LVEF <40), will be recorded after collection of their signed informed consent agreement. Patients will be addressed from heart failure intensive care units for coronary (USIC) or acute cardiac services to the rehabilitation department. Patients will be admitted in the rehabilitation department when there are clinically stable (at least three weeks after the acute episode). Etiology of the heart failure will be assessed and patients stratified as C or NC patients.
Expected Results We will estimate the mean duration of inpatient rehabilitation (H period). Then, we will follow patients' cardiac evaluation parameters recorded from an outpatient follow-up, first 3 months after inclusion and then every 6 months over the 24 months of outpatient follow-up.
These data will allow for comparison of the benefits of rehabilitation between coronary (C) and non-coronary (NC) patients for each evaluation time point and will give information on the clinical improvement of each group of patients.
Studientyp
Einschreibung (Voraussichtlich)
Kontakte und Standorte
Studienorte
-
-
-
Corbeil, Frankreich, 91100
- Rekrutierung
- Centre Hospitalien Sud Francilien
-
Kontakt:
- Francois Koukoui, MD
- Telefonnummer: 00(33)161698086
- E-Mail: francois.koukoui@ch-sud-francilien.fr
-
Hauptermittler:
- Francois Koukoui, MD
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Probenahmeverfahren
Studienpopulation
Beschreibung
Inclusion Criteria:
- Age over 18 years old,
- Signed informed consent,
- Patients with left ventricular ejection fraction below 40 %,
- Stable for over 3 weeks,
- Known etiology,
- Able to do the performance test on treadmil or bicycle in order to have rehabilitation.
- No clinical avoidance reasons.
- Patient with health care registration.
- Agreement from the general practictioner and from the cardiologist that follows the patient.
Exclusion Criteria:
- Age below 18 years old,
- Unstable heart failure,
- Unable to do a performance test as indicated above,
- Patients not able to understand clinical counseling.
- Patient under tutella.
- Pregnancy.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
Kohorten und Interventionen
Gruppe / Kohorte |
---|
Non coronary patients (NC)
Patient with myocardial infarction with non-coronary (NC) etiology
|
Coronary patients (C)
Patients with myocardial infarction due to coronary disease
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Change in VO2max every 6 months over the 24 months
Zeitfenster: every 6 months over the 24 months of outpatient follow-up
|
VO2max (L)
|
every 6 months over the 24 months of outpatient follow-up
|
Change in Left ventricular ejection fraction every 6 months over the 24 months of outpatient follow-up
Zeitfenster: every 6 months over the 24 months of outpatient follow-up
|
Left ventricular ejection fraction (ultrasound method and/or isotopic) in %
|
every 6 months over the 24 months of outpatient follow-up
|
Change on 6-min walk test every 6 months over the 24 months
Zeitfenster: every 6 months over the 24 months of outpatient follow-up
|
6-min walk test (m)
|
every 6 months over the 24 months of outpatient follow-up
|
Change on Minnesota index of quality of life every 6 months over the 24 months
Zeitfenster: every 6 months over the 24 months of outpatient follow-up
|
Minnesota index of quality of life.
|
every 6 months over the 24 months of outpatient follow-up
|
Change on heart rate every 6 months over the 24 months
Zeitfenster: every 6 months over the 24 months of outpatient follow-up
|
Heart rate (bpm)
|
every 6 months over the 24 months of outpatient follow-up
|
Change on systolic blood pressure every 6 months over the 24 months
Zeitfenster: every 6 months over the 24 months of outpatient follow-up
|
systolic blood pressure (mmHg)
|
every 6 months over the 24 months of outpatient follow-up
|
Change on diastolic blood pressure every 6 months over the 24 months
Zeitfenster: every 6 months over the 24 months of outpatient follow-up
|
diastolic blood pressure (mmHg)
|
every 6 months over the 24 months of outpatient follow-up
|
Change on body mass index every 6 months over the 24 months
Zeitfenster: every 6 months over the 24 months of outpatient follow-up
|
Measurement of weight and height, calculation of body mass index (kg/m2)
|
every 6 months over the 24 months of outpatient follow-up
|
Change on creatine clearance every 6 months over the 24 months
Zeitfenster: every 6 months over the 24 months of outpatient follow-up
|
creatine clearance (ml/min)
|
every 6 months over the 24 months of outpatient follow-up
|
Mitarbeiter und Ermittler
Publikationen und hilfreiche Links
Allgemeine Veröffentlichungen
- Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K; ESC Committee for Practice Guidelines (CPG). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J. 2008 Oct;29(19):2388-442. doi: 10.1093/eurheartj/ehn309. Epub 2008 Sep 17. No abstract available. Erratum In: Eur Heart J. 2010 Apr;12(4):416. Dosage error in article text. Eur Heart J. 2010 Mar;31(5):624. Dosage error in article text.
- Koukoui F, Desmoulin F, Lairy G, Bleinc D, Boursiquot L, Galinier M, Smih F, Rouet P. Benefits of cardiac rehabilitation in heart failure patients according to etiology: INCARD French study. Medicine (Baltimore). 2015 Feb;94(7):e544. doi: 10.1097/MD.0000000000000544.
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn
Primärer Abschluss (Voraussichtlich)
Studienabschluss (Voraussichtlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Schätzen)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Schätzen)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- INCARD
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Herzfehler
-
Region SkaneAnmeldung auf EinladungHerzinsuffizienz New York Heart Association (NYHA) Klasse II | Herzinsuffizienz New York Heart Association (NYHA) Klasse IIISchweden
-
Medical University of BialystokInstitute of Cardiology, Warsaw, Poland; Medical University of Lodz; Poznan University... und andere MitarbeiterNoch keine RekrutierungHerzinsuffizienz, systolisch | Herzinsuffizienz mit reduzierter Ejektionsfraktion | Herzinsuffizienz New York Heart Association Klasse IV | Herzinsuffizienz New York Heart Association Klasse IIIPolen
-
University of WashingtonAmerican Heart AssociationAbgeschlossenHerzinsuffizienz, kongestive | Mitochondriale Veränderung | Herzinsuffizienz New York Heart Association Klasse IVVereinigte Staaten
-
Abbott Medical DevicesThoratec CorporationAbgeschlossenDriveline Heart-assisted Device Related InfectionVereinigte Staaten
-
Mezzion Pharma Co. LtdNational Heart, Lung, and Blood Institute (NHLBI); Pediatric Heart NetworkAbgeschlossenSingle Ventricle Heart Disease nach Fontan-OperationVereinigte Staaten, Kanada
-
Medical University of South CarolinaAmerican Heart AssociationAbgeschlossenSingle Ventricle Heart Disease nach Fontan-OperationVereinigte Staaten
-
University Hospital, GasthuisbergUnbekanntTransient Left Ventricular Ballooning SyndromeBelgien
-
NYU Langone HealthRekrutierungTako-Tsubo-Kardiomyopathie | Takotsubo-Kardiomyopathie | Broken-Heart-SyndromVereinigte Staaten
-
French Cardiology SocietyAbgeschlossen